Banaras Hindu University, Varanasi, India Institute of Tropical Medicine, Antwerp, Belgium Barcelona Centre for International Health Research (CRESIB, Hospital Clínic-Universitat de Barcelona), Barcelona, Spain Geneva University Hospitals, Geneva, Switzerland.
Trop Med Int Health. 2012 Nov;17(11):1345-8. doi: 10.1111/j.1365-3156.2012.03067.x. Epub 2012 Aug 12.
We assessed the prevalence of post-kala-azar dermal leishmaniasis (PKDL), a late cutaneous manifestation of visceral leishmaniasis (VL), in 16 VL-endemic communities in Bihar, India. The prevalence of confirmed PKDL cases was 4.4 per 10 000 individuals and 7.8 if probable cases were also considered. The clinical history and treatment of the post-kala-azar dermal leishmaniasis cases are discussed.
我们评估了印度比哈尔邦 16 个内脏利什曼病(VL)流行社区中,作为内脏利什曼病(VL)晚期皮肤表现的黑热病后皮肤利什曼病(PKDL)的流行情况。确诊 PKDL 病例的流行率为每 10000 人 4.4 例,如果也考虑可能病例,则为 7.8 例。讨论了 PKDL 病例的临床病史和治疗情况。